TY - CHAP M1 - Book, Section TI - Bibliografía A1 - Stern, Scott D.C. A1 - Cifu, Adam S. A1 - Altkorn, Diane PY - 2021 T2 - Diagnóstico basado en los síntomas: Una guía basada en evidencias, 4e AB - Chou R, Dana T. Screening adults for bladder cancer: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2010;153(7):461–8.[PubMed: ]Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med. 2005 Dec 8;353(23):2477–90.Cohen RA, Brown RS. Clinical practice. Microscopic hematuria. N Engl J Med. 2003 Jun 5;348(23):2330–8.Davis R, Jones JS, Barocas DA et al. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol. 2012 Dec;188(6 Suppl):2473–81.Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport’s syndrome, Goodpasture’s syndrome, and type IV collagen. N Engl J Med. 2003 Jun 19;348(25):2543–56.Kanjanabuch T, Kittikowit W, Eiam-Ong S. An update on acute postinfectious glomerulonephritis worldwide. Nat Rev Nephrol. 2009 May;5(5):259–69.Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet. 2009 Jul 18;374(9685):239–49.Nielsen M, Qaseem A. Hematuria as a marker of occult urinary tract cancer: advice for the high-value care from the American College of Physicians. Ann Intern Med. 2016;164(7):488–98.[PubMed: ]O’Connor OJ, McSweeney SE, Maher MM. Imaging of hematuria. Radiol Clin North Am. 2008;46:113.[PubMed: ]Wyatt RJ, Julian BA. IgA Nephropathy. N Engl J Med. 2013;368(25):2402–14.[PubMed: ] SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accessmedicina.mhmedical.com/content.aspx?aid=1185265214 ER -